Evidence map›Paper›PMID 35774273›Full record

ArticleBioMed research international2022

COL8A1 Predicts the Clinical Prognosis of Gastric Cancer and Is Related to Epithelial-Mesenchymal Transition.

Yali She, Xiaowen Zhao, Pingfan Wu, Ling Xue, Shengfang Wan, Lei Zhang, Changtian Li, Hui Cai, Yaling Li

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Type VIII collagen: advances in matrix biology and translational promise.Frontiers in bioengineering and biotechnology · 2025
    Pooled it
  2. COL8A1 regulates endothelial phenotype in inflammatory endothelial-to-mesenchymal transition.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yali SheDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0001-9298-3873
Xiaowen ZhaoDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0001-6640-5658
Pingfan WuDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0002-7066-2048
Ling XueDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Shengfang WanDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Lei ZhangDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Changtian LiDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Hui CaiKey Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, Gansu 730000, China.ORCID https://orcid.org/0000-0002-6182-966X
Yaling LiDepartment of Pathology, School of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0001-7828-6852
Gansu University of Traditional Chinese Medicine · CNGansu Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) is the fifth most common malignant tumor and the third leading cause of cancer-related deaths. Because GC has the characteristics of high heterogeneity, unclear mechanism, limited treatment methods, and low five-year survival rate, it is necessary to find the prognostic biomarkers of GC and explore the mechanism of GC. Methods: We first identified differentially expressed genes (DEGs) between gastric cancer and normal gastric cells through expression analysis. A protein-protein interaction (PPI) network was constructed to find tightly connected modules. We performed survival analysis on the DEGs in the modules to identify genes with prognostic significance. Gene set enrichment analysis (GSEA) was used to identify gene enrichment pathways. Finally, we used our own collected clinical samples of 119 gastric adenocarcinoma (STAD) tissues and 40 normal gastric tissues to perform immunohistochemical (IHC) staining to verify the differential expression of COL8A1 in STAD tissues and normal gastric tissues and its correlation with epithelial-mesenchymal transition- (EMT-) related factors. Results: We identified 356 DEGs through differential expression analysis. Through PPI analysis and survival analysis, we determined that the collagen type VII alpha-1 chain (COL8A1) gene has prognostic significance. GSEA analysis showed that COL8A1 was significantly enriched in the EMT. IHC results showed that COL8A1 was upregulated in STAD tissues and could be used as an independent prognostic factor and was related to EMT. Conclusion: This study shows that COL8A1 is related to the prognosis of GC patients and might affect the progress of GC through the EMT pathway. Therefore, COL8A1 may be a biomarker for predicting the prognosis of GC.

Indexed as

Stomach NeoplasmsBiomarkers, TumorEpithelial-Mesenchymal TransitionGene Expression ProfilingGene Expression Regulation, NeoplasticHumansPrognosisBiomarkers, Tumor

Identifiers

PMID35774273
PMCPMC9239809
OpenAlexW4283275064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.